Atrial fibrillation (AF) is the most common arrhythmia in Europe affecting more than 6 million people. AF is associated with significant mortality and morbidity including an increased risk for stroke, dementia and heart failure. Thus, AF is a major healthcare burden.The pathophysiology of AF is complex and still not fully understood. Increasing data support a genetic component to AF. Genome-wide a ...